Home LiteratureArticle Details
PMID: 18095711 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Fibroblast activation protein peptide substrates identified from human collagen I derived gelatin cleavage sites.

Biochemistry ·Vol. 47 ·No. 3 ·2008-01-22 ·Pages 1076-86

Aggarwal S, Brennen WN, Kole TP, Schneider E, Topaloglu O, Yates M, Cotter RJ, Denmeade SR

Abstract

A highly consistent trait of tumor stromal fibroblasts is the induction of the membrane-bound serine protease fibroblast activation protein-alpha (FAP), which is overexpressed on the surface of reactive stromal fibroblasts present within the stroma of the majority of human epithelial tumors. In contrast, FAP is not expressed by tumor epithelial cells or by fibroblasts or other cell types in normal tissues. The proteolytic activity of FAP, therefore, represents a potential pan-tumor target that can be exploited for the release of potent cytotoxins from inactive prodrugs consisting of an FAP peptide substrate coupled to a cytotoxin. To identify FAP peptide substrates, we used liquid chromatography tandem mass spectroscopy based sequencing to generate a complete map of the FAP cleavage sites within human collagen I derived gelatin. Positional analysis of the frequency of each amino acid at each position within the cleavage sites revealed FAP consensus sequences PPGP and (D/E)-(R/K)-G-(E/D)-(T/S)-G-P. These studies further demonstrated that ranking cleavage sites based on the magnitude of the LC/MS/MS extracted ion current predicted FAP substrates that were cleaved with highest efficiency. Fluorescence-quenched peptides were synthesized on the basis of the cleavage sites with the highest ion current rankings, and kinetic parameters for FAP hydrolysis were determined. The substrate DRGETGP, which corresponded to the consensus sequence, had the lowest Km of 21 microM. Overall the Km values were relatively similar for both high and low ranked substrates, whereas the kcat values differed by up to 100-fold. On the basis of these results, the FAP consensus sequences are currently being evaluated as FAP-selective peptide carriers for incorporation into FAP-activated prodrugs.

MeSH Terms
Amino Acid Sequence Antigens, Neoplasm/chemistry,genetics Biomarkers, Tumor/chemistry,genetics Catalysis Chromatography, Liquid Collagen Type I/chemistry,genetics Consensus Sequence Endopeptidases Fluorescent Dyes/chemistry Gelatin/chemistry,genetics Gelatinases/chemistry Humans Kinetics Membrane Proteins Molecular Sequence Data Peptide Fragments/analysis Peptides/chemistry Recombinant Proteins/chemistry,isolation & purification Serine Endopeptidases/chemistry,genetics Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization Substrate Specificity Tandem Mass Spectrometry
Chemicals
Antigens, Neoplasm Biomarkers, Tumor Collagen Type I Fluorescent Dyes Membrane Proteins Peptide Fragments Peptides Recombinant Proteins Gelatin Endopeptidases Serine Endopeptidases fibroblast activation protein alpha Gelatinases
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
Aggarwal Saurabh
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, The Johns Hopkins University, Baltimore, Maryland 21231, USA.
Brennen W Nathaniel
Kole Thomas P
Schneider Elizabeth
Topaloglu Ozlem
Yates Melinda
Cotter Robert J
Denmeade Samuel R
References (32)
32 references, click to expand
  1. Use of methotrexate-based peptide substrates to characterize the substrate specificity of prostate-specific membrane antigen (PSMA).
    Cancer Biol Ther. 2004 Jun;3(6):551-8 PMID: 15044850
  2. Substrate specificity of human collagenase 3 assessed using a phage-displayed peptide library.
    J Biol Chem. 2000 Oct 6;275(40):31422-7 PMID: 10906330
  3. Purification and characterization of Clostridium perfringens 120-kilodalton collagenase and nucleotide sequence of the corresponding gene.
    J Bacteriol. 1994 Jan;176(1):149-56 PMID: 8282691
  4. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation.
    Cell. 1991 Jan 25;64(2):327-36 PMID: 1703045
  5. A 170-kDa membrane-bound protease is associated with the expression of invasiveness by human malignant melanoma cells.
    Proc Natl Acad Sci U S A. 1990 Nov;87(21):8296-300 PMID: 2172980
  6. Expression and characterization of a low molecular weight recombinant human gelatin: development of a substitute for animal-derived gelatin with superior features.
    Protein Expr Purif. 2005 Apr;40(2):346-57 PMID: 15766877
  7. Host microenvironment in breast cancer development: epithelial-cell-stromal-cell interactions and steroid hormone action in normal and cancerous mammary gland.
    Breast Cancer Res. 2003;5(4):208-15 PMID: 12817994
  8. Enzymatic activation of a doxorubicin-peptide prodrug by prostate-specific antigen.
    Cancer Res. 1998 Jun 15;58(12):2537-40 PMID: 9635575
  9. Synthesis of positional-scanning libraries of fluorogenic peptide substrates to define the extended substrate specificity of plasmin and thrombin.
    Nat Biotechnol. 2000 Feb;18(2):187-93 PMID: 10657126
  10. Molecular cloning of fibroblast activation protein alpha, a member of the serine protease family selectively expressed in stromal fibroblasts of epithelial cancers.
    Proc Natl Acad Sci U S A. 1994 Jun 7;91(12):5657-61 PMID: 7911242
  11. Substrate phage: selection of protease substrates by monovalent phage display.
    Science. 1993 May 21;260(5111):1113-7 PMID: 8493554
  12. Recombinant expression systems for the production of collagen.
    Biochem Soc Trans. 2000;28(4):350-3 PMID: 10961917
  13. Mass spectrometric approaches for the identification of gel-separated proteins.
    Electrophoresis. 1995 Oct;16(10):1791-814 PMID: 8586048
  14. Pharmacokinetics, biodistribution, and antitumor efficacy of a human glandular kallikrein 2 (hK2)-activated thapsigargin prodrug.
    Prostate. 2006 Mar 1;66(4):358-68 PMID: 16302271
  15. Expression, purification, and kinetic characterization of full-length human fibroblast activation protein.
    Protein Expr Purif. 2002 Mar;24(2):274-81 PMID: 11858723
  16. Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast.
    Clin Cancer Res. 1999 May;5(5):1041-56 PMID: 10353737
  17. Cell-surface glycoproteins of human sarcomas: differential expression in normal and malignant tissues and cultured cells.
    Proc Natl Acad Sci U S A. 1988 May;85(9):3110-4 PMID: 2896356
  18. Selective inhibition of fibroblast activation protein protease based on dipeptide substrate specificity.
    J Biol Chem. 2006 Mar 17;281(11):7437-44 PMID: 16410248
  19. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing.
    N Engl J Med. 1986 Dec 25;315(26):1650-9 PMID: 3537791
  20. Cell surface glycoprotein of reactive stromal fibroblasts as a potential antibody target in human epithelial cancers.
    Proc Natl Acad Sci U S A. 1990 Sep;87(18):7235-9 PMID: 2402505
  21. Screening a combinatorial peptide library to develop a human glandular kallikrein 2-activated prodrug as targeted therapy for prostate cancer.
    Mol Cancer Ther. 2004 Nov;3(11):1439-50 PMID: 15542783
  22. Effect of fibroblast activation protein and alpha2-antiplasmin cleaving enzyme on collagen types I, III, and IV.
    Arch Biochem Biophys. 2007 Jan 15;457(2):177-86 PMID: 17174263
  23. Characterization of the peptide substrate specificities of interstitial collagenase and 92-kDa gelatinase. Implications for substrate optimization.
    J Biol Chem. 1994 Dec 30;269(52):32814-20 PMID: 7806505
  24. Purification of tadpole collagenase and characterization using collagen and synthetic substrates.
    Biochim Biophys Acta. 1979 Jan 12;566(1):211-21 PMID: 83165
  25. Prostate-specific antigen-activated thapsigargin prodrug as targeted therapy for prostate cancer.
    J Natl Cancer Inst. 2003 Jul 2;95(13):990-1000 PMID: 12837835
  26. The substrate specificity of Uca pugilator collagenolytic serine protease 1 correlates with the bovine type I collagen cleavage sites.
    J Biol Chem. 1994 Jul 29;269(30):19565-72 PMID: 8034725
  27. A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas.
    Nature. 1990 Dec 20-27;348(6303):699-704 PMID: 1701851
  28. Fibroblast activation protein, a dual specificity serine protease expressed in reactive human tumor stromal fibroblasts.
    J Biol Chem. 1999 Dec 17;274(51):36505-12 PMID: 10593948
  29. Biochemical characterization of human collagenase-3.
    J Biol Chem. 1996 Jan 19;271(3):1544-50 PMID: 8576151
  30. Tumor stroma as a regulator of neoplastic behavior. Agonistic and antagonistic elements embedded in the same connective tissue.
    Lab Invest. 1995 Aug;73(2):157-60 PMID: 7637316
  31. Identification of the 170-kDa melanoma membrane-bound gelatinase (seprase) as a serine integral membrane protease.
    J Biol Chem. 1997 Mar 21;272(12):7595-601 PMID: 9065413
  32. Fibroblast activation protein-alpha and dipeptidyl peptidase IV (CD26): cell-surface proteases that activate cell signaling and are potential targets for cancer therapy.
    Drug Resist Updat. 2005 Feb-Apr;8(1-2):51-8 PMID: 15939342
Article Info
Journal
Biochemistry
Abbr.
Biochemistry
ISSN
0006-2960
Published
2008-01-22
Epub
2007-00-21
Pages
1076-86
Language
English
Region
United States
NLM ID
0370623
PMCID
PMC4696028
Subset
IM
Grants
NCI NIH HHS · P30 CA006973 · United States
NCRR NIH HHS · 1S10-RR14702 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com